Clinical Trials

Non-Muscle Invasive Bladder Neoplasms

NCT06173349 2026-03-13

PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

12 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07000084 2026-03-04

GAIN-BCG

Phase 3 Recruiting

330 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07130578 2026-03-03

The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer

60 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06245603 2026-02-06

Hydeal Cyst

200 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT07225127 2026-02-05

CISTO2

408 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06733363 2026-01-27

A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer

344 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07339761 2026-01-14

SPICE

30 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05962541 2025-12-31

CUT-less

Phase 4 Recruiting

327 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05327647 2025-12-18

BicaBCa

160 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05672615 2025-11-18

Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG

42 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06929286 2025-10-30

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

Phase 3 Recruiting

125 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06781879 2025-10-03

COBRA-NMIBC

Phase 4 Recruiting

272 enrolled

Non-Muscle Invasive Bladder Neoplasms, Recurrence

NCT06704191 2025-09-22

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Phase 1/2 Recruiting

40 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07187063 2025-09-22

Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer

56 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06351904 2025-09-11

A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy

72 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05126472 2025-09-04

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

55 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05825950 2025-08-17

Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

600 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07036731 2025-06-25

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

428 enrolled

Non-Muscle Invasive Bladder Neoplasms, Fanconi Syndrome

NCT07019220 2025-06-13

COBRA

47 enrolled

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

NCT06972771 2025-05-30

Trop2-targeting NIR-II Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer

30 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT04375813 2025-05-15

eRapa

166 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05002556 2025-04-30

TVNIM-AFU

8,000 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06889623 2025-03-21

HIGCrecur

72 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06735287 2025-03-18

A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer

60 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06696794 2025-02-19

Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients

Phase 3 Recruiting

180 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT03317158 2025-01-30

ADAPT-BLADDER

Phase 1/2 Recruiting

55 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT05790850 2024-12-16

PRIMER

30 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Motor Activity

NCT04106115 2024-12-04

DURANCE

Phase 1/2 Recruiting

64 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06632964 2024-10-09

A Clinical Trial Aimed At Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer

16 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06187506 2024-07-12

Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer

20 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT03973671 2024-03-28

ProCaB

300 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT06287541 2024-03-01

The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection

428 enrolled

Non-Muscle Invasive Bladder Neoplasms, Fanconi Syndrome

NCT03379909 2023-09-21

TROJAN

49 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05957757 2023-08-31

RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression

20 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05337397 2022-08-08

OPTIMA

145 enrolled